Back to Capital World Investors Capital World Investors

KRYSKRYS
Showing 8 of 10 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in Krystal Biotech, Inc.

Capital World Investors holds 777,843 shares of KRYS (Krystal Biotech, Inc.), worth $289.1M as of 2026-Q2. The position was decreased (-5.7% shares). KRYS represents 0.0% of Capital World Investors's portfolio.

Current Value

$289.1M

Current Shares

777,843

Total Value Change

+$129.1M

Total Shares Change

-101,240

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
777,843
-5.7%
$289.1M0.0%$371.67
0
2026-Q1
Increased
824,720
+1.9%
$213M0.0%$263.80
31
2025-Q4
Increased
809,500
+0.0%
$199.6M0.0%$247.88
30
2025-Q3
Decreased
809,240
-14.1%
$142.9M0.0%$176.75
0
2025-Q2
Decreased
942,249
-1.3%
$129.5M0.0%$138.88
0
2025-Q1
Increased
954,468
+8.6%
$172.1M0.0%$183.92
33
2024-Q4
Increased
879,203
+0.0%
$137.7M0.0%$159.80
30
2024-Q3
Increased
879,083
+0.1%
$160M0.0%$177.14
30

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used